< Residency/PhD Program < How to Apply < Residency/PhD Program Application Area
Available Laboratories
The available positions for the Physician Scientist call are 12.
The following is the list of the 52 laboratories available to host a PhD.
|
Surname & Name
|
Research center/University
|
Research Areas
|
Title of the project
|
Description
|
|---|---|---|---|---|
|
Università degli Studi della Campania Luigi Vanvitelli
|
Molecular Therapy
|
Advancing Novel Epigenetic-Based Strategies to Target CRC
|
||
|
Università degli Studi di Torino
|
Molecular Therapy
|
Decoding tumor evolution to optimize sequential RAS-targeted therapies
|
||
|
IFOM - Istituto Fondazione di Oncologia Molecolare, ETS
|
Cancer Biology
|
Proteomic profiling of epitheliod sarcoma to identify diagnostic markers and clinically actionable pathways
|
||
|
Università degli Studi di Torino
|
Genomic Medicine
|
Targeting Metastatic Prowess with Translational Oncology
|
||
|
Università degli Studi di Milano
|
Neurobiology
|
Personalized Function-based resection for IDH-mutant glioma patients
|
||
|
Università degli Studi di Firenze
|
Computational Biology
|
Tracking non-tumor-derived cfDNA in longitudinal liquid biopsies to monitor treatment response in metastatic cancer
|
||
|
Fondazione Casa Sollievo della Sofferenza - I.R.C.C.S.
|
Cancer Biology
|
The Role of Non-coding RNA in Lung Cancer Progression and Chemo-Immunotherapy Response
|
||
|
Fondazione "Istituto Nazionale Genetica Molecolare - INGM"
|
Molecular Biology
|
Translational development of LINE1-targeting RNA therapeutics to restore anti-tumor T-cell function
|
||
|
Humanitas Mirasole S.p.A.
|
Cancer Biology
|
Translational and clinical activities related to trials for oral cancer prevention and treatment
|
||
|
Università degli Studi di Udine
|
Cancer Biology
|
Targeting Epigenetic and 3D Genome Vulnerabilities in Uterine Leiomyosarcoma
|
||
|
Università degli Studi di Milano
|
Molecular Biology
|
The methylate SMYD3 Links Chromosomal Instability to the Cytosolic DNA Sensing in Breast Cancer
|
||
|
Istituto Europeo di Oncologia I.R.C.C.S. S.r.l.
|
Cancer Biology
|
Unraveling the ovarian cancer immune microenvironment and its response to immunotherapy through patient-derived models
|
||
|
Fondazione M. Tettamanti M. De Marchi Onlus
|
Cancer Biology
|
Predisposition to childhood acute lymphoblastic leukemia: from genes to families and back
|
||
|
Università degli Studi di Torino
|
Molecular Therapy
|
In vivo transduction of engineered TCRs for next-generation lung cancer therapy
|
||
|
Università degli Studi di Napoli "Federico II"
|
Cancer Biology
|
aptamer-based liquid biospy on EVs from breast cancer
|
||
|
IFOM - Istituto Fondazione di Oncologia Molecolare, ETS
|
Cancer Biology
|
Replication-stress-driven re-programming and immune escape in aggressive human cancers
|
||
|
Università degli Studi di Modena e Reggio Emilia
|
Molecular Therapy
|
Multi-Omics studies of the Mechanism and Toxicity of a Novel Anticancer Drug in Colorectal Cancer
|
||
|
Università Humanitas
|
Cancer Biology
|
Functional validation of clonal evolution patterns in myelodysplastic syndromes using bone marrow organoids
|
||
|
Università degli Studi di Trento
|
Genomic Medicine
|
Functional and Liquid Biopsy Genomics to Characterize PARP Inhibitor Responses in Prostate Cancer
|
||
|
Università degli Studi di Milano - Bicocca
|
Immunology
|
Spatial Multi-Omics Mapping of the Intestinal Microenvironment in Colitis-Associated Cancer
|
||
|
Fondazione M. Tettamanti M. De Marchi Onlus
|
Cancer biology
|
Advanced proteomic characterization of relapse and immunotherapy resistance in PAX5-rearranged pediatric B-cell Leukemia
|
||
|
Humanitas Mirasole S.p.A.
|
Cancer Biology
|
Targeting PBX as a novel therapy for myeloproliferative neoplasm: effect on disease course through innovative assays.
|
||
|
Università degli Studi di Bari Aldo Moro
|
Cancer Biology
|
Human Genetically Defined PDAC Organoids to Identify Early Diagnostic Biomarkers
|
||
|
Università degli Studi di Torino
|
Cancer Biology
|
Multiplexed single-cell measurements of ERK/JNK/p38 dynamics to predict colorectal cancer response to chemotherapy
|
||
|
Fondazione "Istituto Nazionale Genetica Molecolare - INGM"
|
Immunology
|
Dissecting the IL-10/IL10R axis in human Melanoma: Spatial immunophenotyping to predict immunotherapy response.
|
||
|
Giacomini Arianna
|
Università degli Studi di Brescia
|
Cancer Biology
|
Novel small molecule FGF traps as drug candidates for cancer therapy: from biophysical screening to in vivo validation
|
|
|
Iannacone Matteo
|
Università Vita-Salute San Raffaele
|
Immunology
|
Restoring Immune Surveillance in Liver Tumors through Endothelial Reprogramming
|
|
|
Humanitas Mirasole S.p.A.
|
Immunology
|
Biomarkers of anti-tumor response in solid tumors treated with combination immunotherapy targeting immunosuppression
|
||
|
Università degli Studi di Genova
|
Immunology
|
Reprogramming NK cell dysfunction in breast and ovarian cancers to enhance immunotherapy efficacy
|
||
|
Fondazione Pisana per la Scienza Onlus
|
Cancer Biology
|
Beyond Pathology: Integrating FLIM and MALDI Imaging for Hidden Ultrastructural Insights in Glioblastoma
|
||
|
Università degli Studi di Firenze
|
Cancer Biology
|
Investigating the role of peroxisomes in modulating radiotherapy response in breast cancer
|
||
|
Università degli Studi di Torino
|
Cancer Biology
|
Platelet function evaluation in patient with lung cancer
|
||
|
Università degli Studi di Milano
|
Molecular Biology
|
A novel gene modulating genomic instability in cancer cells: mechanisms and functions in chromatin regulation
|
||
|
Università Vita-Salute San Raffaele
|
Cancer Biology
|
Single-cell predictors biomarkers of sacituzumab govitecan (SG) or SG + pembrolizumab in muscle-invasive bladder cancer
|
||
|
Università degli Studi del Piemonte Orientale "Amedeo Avogadro"
|
Cancer Biology
|
DEMO-BRCA: Deciphering the Epigenetic and Microenvironmental Modifiers of BRCA1/2-Driven Tumor Onset
|
||
|
Università degli Studi di Roma "La Sapienza"
|
Genomic Medicine
|
Dissecting Male Breast Cancer: Inherited Risk, Tumor Biology and Multi-Omics Integration for Clinical Translation
|
||
|
IFOM - Istituto Fondazione di Oncologia Molecolare, ETS
|
Cancer Biology
|
Mapping the Spatial Microenvironment and Cellular Plasticity in Metastatic Colo-rectal cancer
|
||
|
Istituto Europeo di Oncologia I.R.C.C.S. S.r.l.
|
Cancer Biology
|
Uncovering Therapeutic Vulnerabilities in EZH2-Mutant Germinal Center Lymphomas
|
||
|
Istituto Europeo di Oncologia I.R.C.C.S. S.r.l.
|
Cancer Biology
|
Targeting metabolic vulnerabilities of circulating tumor cells to prevent metastatic relapse
|
||
|
Università degli Studi di Pavia
|
Cancer Biology
|
Dissecting the molecular underpinnings of clinically relevant NET cell states to improve patients' outcome
|
||
|
Università degli Studi di Milano - Bicocca
|
Cancer Biology
|
Towards new therapeutic approaches for the treatment of SETBP1-driven leukemias
|
||
|
Università degli Studi di Napoli "Federico II"
|
Cancer Biology
|
Targeting thyroid hormone signaling to overcome cancer-related fatigue driven by tyrosine-kinase inhibitors
|
||
|
Istituto Europeo di Oncologia I.R.C.C.S. S.r.l.
|
Cancer Biology
|
Molecular and clinical characterization of micronuclei in chromosomally-unstable tumors
|
||
|
Fondazione M. Tettamanti M. De Marchi Onlus
|
Cancer Biology
|
Multifunctional CARs for enhanced leukemic stem cell targeting and bone marrow homing
|
||
|
Università Cattolica del Sacro Cuore
|
Cancer Biology
|
Extracellular Vesicle-Mediated Tumor Evolution and Adaptive Resistance in Advanced High-Grade Serous Ovarian Cancer
|
||
|
Università degli Studi di Trento
|
Cancer Biology
|
CAR-T Therapy for Glioblastoma
|
||
|
Università Vita-Salute San Raffaele
|
Molecular Therapy
|
Targeting mitochondria to prevent cancer tolerance and persistency
|
||
|
IFOM - Istituto Fondazione di Oncologia Molecolare, ETS
|
Cancer Biology
|
Perturbed hematopoiesis as a systemic driver of cancer evolution
|
||
|
Università Humanitas
|
Genomic Medicine
|
Modeling PAM variants in ACTH-secreting pituitary tumors using human organoids
|
||
|
Università degli Studi di Verona
|
Immunology
|
Tumor-Hijacked Monocytes as Drivers of Cancer Progression, Metastasis and Response to Immunotherapy
|
||
|
Università Vita-Salute San Raffaele
|
Cancer Biology
|
Genetic and Epigenetic Trajectories of Immune Escape in Post-Transplant AML Relapse
|
||
|
Università degli Studi di Firenze
|
Genomic Medicine
|
Addressing complexity of leukemia genome by chromatin 3D structure analysis
|
Go to the APPLICATION AREA